Related Experiment Video
Updated: Jun 23, 2026

07:17
Purification of Hsp104, a Protein Disaggregase
Published on: September 30, 2011
Purification and functional characterization of phiX174 lysis protein E
Yi Zheng1, Douglas K Struck, Ry Young
1Department of Biochemistry and Biophysics, Texas A&M University, 2128 TAMU, College Station, Texas 77843-2128, USA.
Biochemistry
|April 22, 2009
Summary
Bacteriophage protein E is purified and shown to be a noncompetitive inhibitor of MraY, a key enzyme in bacterial cell wall synthesis. This finding refines our understanding of how E inactivates MraY, impacting bacterial lysis mechanisms.
Area of Science:
- Bacteriology and Virology
- Molecular Biology
- Biochemistry
Background:
- Bacteriophages employ "protein antibiotics" to lyse host cells by inhibiting cell wall biosynthesis.
- The bacteriophage protein E is a known inhibitor of MraY, an essential enzyme in bacterial murein precursor synthesis.
Purpose of the Study:
- To purify the bacteriophage protein E, which has been challenging due to its lethality.
- To elucidate the inhibitory mechanism of protein E on the MraY enzyme.
- To reconcile conflicting previous findings regarding E's inhibition of membrane-embedded versus solubilized MraY.
Main Methods:
- Purification of bacteriophage protein E from Escherichia coli.
- Enzyme inhibition assays using a fluorescently labeled substrate analogue to study MraY activity.
- Analysis of MraY mutant proteins selected for resistance to protein E, correlating in vitro and in vivo data.
Main Results:
- Protein E was successfully purified, overcoming previous overexpression challenges.
- Protein E acts as a noncompetitive inhibitor of detergent-solubilized MraY against both substrate and lipid components.
- Mutations conferring E resistance in MraY correlate with enzyme affinities, supporting a conformational inactivation model.
Conclusions:
- Protein E directly inhibits MraY activity, likely through binding to a transmembrane domain.
- This binding induces a conformational change, inactivating MraY and disrupting bacterial cell wall synthesis.
- The findings propose a revised model for E-mediated MraY inhibition, distinct from previous complex-formation hypotheses.

